Tumor and Serum DNA Methylation in Women Receiving Preoperative Chemotherapy with or without Vorinostat in TBCRC008

BACKGROUND: Methylated gene markers have shown promise in predicting breast cancer outcomes and treatment response. We evaluated whether baseline and change in tissue and serum methylation would predict pathological complete response (pCR) in patients with HER2-negative early breast cancer undergoin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Connolly, Roisin M., Fackler, Mary Jo, Zhang, Zhe, Zhou, Xian C., Goetz, Matthew P., Boughey, Judy C., Walsh, Bridget, Carpenter, John T., Storniolo, Anna Maria, Watkins, Stanley P., Gabrielson, Edward W., Stearns, Vered, Sukumar, Saraswati
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793219/
https://ncbi.nlm.nih.gov/pubmed/28918548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4503-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados